Activation of another tyrosine kinase, c-Src, by the CD44–HA complex stimulates a rearrangement of cytoskeleton proteins and increases migration in breast and ovarian cancers [18, 19, 25]. The gene discussed is SRC; the disease is ovarian carcinoma.